Analyst picks & changes

Biogen Inc.

(BGEN)

Matthew Geller of Oppenheimer & Co. raised his rating on the Cambridge, Mass., company to "buy" and added it to Oppenheimer's "recommended" list. Geller said that BGEN's beta interferon

Read the full 322 word article

How to gain access

Continue reading with a
two-week free trial.